Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1)

Biochem J. 2002 Sep 15;366(Pt 3):807-16. doi: 10.1042/BJ20020202.

Abstract

Gelatinase A transcriptional regulation is the consequence of combinatorial interactions with key promoter and enhancer elements identified within this gene. A potent 40 bp enhancer response element, RE-1, located in the near 5' flanking regions of the rat and human gelatinase A genes drives high-level expression in glomerular mesangial cells (MCs). Southwestern-blot analysis of MC nuclear extracts revealed specific interactions of RE-1 with at least four proteins, of which three have been identified as p53, activator protein 2 and the single-stranded DNA-binding factor Y-box protein-1 (YB-1). In the present study, we report the identification of a fourth 17 kDa RE-1-binding protein as the rat homologue (nm23-beta) of the human nm23-H1 metastasis suppressor gene. Recombinant nm23-beta protein bound only the single-stranded forms of the RE-1 sequence. Mutagenesis revealed direct interaction of nm23-beta with a repeat sequence, 5'-GGGTTT-3', shown previously to specifically interact with YB-1 [Mertens, Harendza, Pollock and Lovett (1997) J. Biol. Chem. 272, 22905-22912], and recombinant nm23-beta protein competed for single-stranded YB-1 binding. Transient transfection of MC with an nm23-beta expression plasmid within the context of a RE-1/simian virus 40 promoter/luciferase reporter yielded a concentration-dependent repression (80-90%) of luciferase activity in MC and Rat1 fibroblasts. A similar pattern of nm23-beta repression was demonstrated within the context of the RE-1/homologous gelatinase A promoter. Co-transfection of nm23-beta blocked YB-1-mediated activation of transcription and expression of gelatinase A. Nm23-beta may be an important physiological regulator of gelatinase A transcription that acts by competitive interference with the single-stranded transactivator YB-1. Gelatinase A is a key mediator of tumour metastasis, suggesting that competitive suppression of transcription by nm23-beta (or the human nm23-H1) may be a component of the reduced metastatic capabilities of cells expressing high levels of this protein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding, Competitive
  • Blotting, Southern
  • Blotting, Western
  • CCAAT-Enhancer-Binding Proteins / metabolism*
  • Cell Division
  • Cell Nucleus / metabolism
  • Cloning, Molecular
  • DNA, Complementary / metabolism
  • DNA-Binding Proteins*
  • Fibroblasts / metabolism
  • Genes, Reporter
  • Humans
  • Luciferases / metabolism
  • Matrix Metalloproteinase 2 / metabolism*
  • Monomeric GTP-Binding Proteins / metabolism*
  • Mutagenesis, Site-Directed
  • Mutation
  • NFI Transcription Factors
  • NM23 Nucleoside Diphosphate Kinases
  • Neoplasm Metastasis
  • Nuclear Proteins
  • Nucleoside-Diphosphate Kinase / metabolism
  • Oligonucleotides / metabolism
  • Plasmids / metabolism
  • Promoter Regions, Genetic
  • RNA, Messenger / metabolism*
  • Rats
  • Recombinant Proteins / metabolism
  • Transcription Factors / metabolism*
  • Transcription, Genetic*
  • Transfection
  • Y-Box-Binding Protein 1

Substances

  • CCAAT-Enhancer-Binding Proteins
  • DNA, Complementary
  • DNA-Binding Proteins
  • NFI Transcription Factors
  • NM23 Nucleoside Diphosphate Kinases
  • Nuclear Proteins
  • Oligonucleotides
  • RNA, Messenger
  • Recombinant Proteins
  • Transcription Factors
  • Y-Box-Binding Protein 1
  • YBX1 protein, human
  • Ybx1 protein, rat
  • Luciferases
  • NME1 protein, human
  • Nucleoside-Diphosphate Kinase
  • Matrix Metalloproteinase 2
  • Monomeric GTP-Binding Proteins